Key result
Atrial fibrillation is exceptionally rare in stable orthotopic heart transplant patients, and its late occurrence should prompt immediate evaluation for acute rejection, transplant vasculopathy, or sepsis.
Arrhythmias in heart transplant recipients are important clinical markers for underlying complications such as rejection and vasculopathy.
Answers are grounded in this paper and cite their sources.
May signal complications in transplant AF; leaves open prospective validation of diagnostic thresholds.
Orthotopic heart transplantation (OHT) is currently the most effective long-term therapy for patients with end-stage cardiac disease, even as left ventricular devices show markedly improved outcomes. As surgical techniques and immunosuppressive regimens have been refined, short-term mortality caused by sepsis has decreased, while morbidity caused by repeated rejection episodes and vasculopathy has increased, and is often manifested by arrhythmias. These chronic transplant complications require early and aggressive multidisciplinary treatment. Understanding the relationship between arrhythmias and these complications in the acute and chronic stages following OHT is critical in improving patient prognosis, as arrhythmias may be the earliest or sole presentation. Finally, decentralised/ denervated hearts represent a unique opportunity to investigate the underlying mechanisms of arrhythmias.
No takes yet. Share an insight, caveat, or question.
Hamon et al. (2014) conducted a review in Arrhythmias post-orthotopic heart transplantation. Atrial fibrillation is exceptionally rare in stable orthotopic heart transplant patients, and its late occurrence should prompt immediate evaluation for acute rejection, transplant vasculopathy, or sepsis.
Synapse has enriched 10 related papers. Consider them for comparative context: